These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 23052204
1. ALCAM/CD166 adhesive function is regulated by the tetraspanin CD9. Gilsanz A, Sánchez-Martín L, Gutiérrez-López MD, Ovalle S, Machado-Pineda Y, Reyes R, Swart GW, Figdor CG, Lafuente EM, Cabañas C. Cell Mol Life Sci; 2013 Feb; 70(3):475-93. PubMed ID: 23052204 [Abstract] [Full Text] [Related]
3. The sheddase activity of ADAM17/TACE is regulated by the tetraspanin CD9. Gutiérrez-López MD, Gilsanz A, Yáñez-Mó M, Ovalle S, Lafuente EM, Domínguez C, Monk PN, González-Alvaro I, Sánchez-Madrid F, Cabañas C. Cell Mol Life Sci; 2011 Oct 13; 68(19):3275-92. PubMed ID: 21365281 [Abstract] [Full Text] [Related]
4. Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration. Swart GW. Eur J Cell Biol; 2002 Jun 13; 81(6):313-21. PubMed ID: 12113472 [Abstract] [Full Text] [Related]
5. Tetraspanin CD9 modulates ADAM17-mediated shedding of LR11 in leukocytes. Tsukamoto S, Takeuchi M, Kawaguchi T, Togasaki E, Yamazaki A, Sugita Y, Muto T, Sakai S, Takeda Y, Ohwada C, Sakaida E, Shimizu N, Nishii K, Jiang M, Yokote K, Bujo H, Nakaseko C. Exp Mol Med; 2014 Apr 04; 46(4):e89. PubMed ID: 24699135 [Abstract] [Full Text] [Related]
6. Modulation of CD6 function through interaction with Galectin-1 and -3. Escoda-Ferran C, Carrasco E, Caballero-Baños M, Miró-Julià C, Martínez-Florensa M, Consuegra-Fernández M, Martínez VG, Liu FT, Lozano F. FEBS Lett; 2014 Aug 25; 588(17):2805-13. PubMed ID: 24945728 [Abstract] [Full Text] [Related]
7. CD9 regulates keratinocyte migration by negatively modulating the sheddase activity of ADAM17. Liu J, Zhu G, Jia N, Wang W, Wang Y, Yin M, Jiang X, Huang Y, Zhang J. Int J Biol Sci; 2019 Aug 25; 15(2):493-506. PubMed ID: 30745837 [Abstract] [Full Text] [Related]
8. CD9 Controls Integrin α5β1-Mediated Cell Adhesion by Modulating Its Association With the Metalloproteinase ADAM17. Machado-Pineda Y, Cardeñes B, Reyes R, López-Martín S, Toribio V, Sánchez-Organero P, Suarez H, Grötzinger J, Lorenzen I, Yáñez-Mó M, Cabañas C. Front Immunol; 2018 Aug 25; 9():2474. PubMed ID: 30455686 [Abstract] [Full Text] [Related]
9. Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function. Ikeda K, Quertermous T. J Biol Chem; 2004 Dec 31; 279(53):55315-23. PubMed ID: 15496415 [Abstract] [Full Text] [Related]
10. Activated leukocyte cell adhesion molecule is a component of the endothelial junction involved in transendothelial monocyte migration. Masedunskas A, King JA, Tan F, Cochran R, Stevens T, Sviridov D, Ofori-Acquah SF. FEBS Lett; 2006 May 15; 580(11):2637-45. PubMed ID: 16650408 [Abstract] [Full Text] [Related]
11. Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166. von Lersner A, Droesen L, Zijlstra A. Clin Exp Metastasis; 2019 Apr 15; 36(2):87-95. PubMed ID: 30778704 [Abstract] [Full Text] [Related]
12. Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody. Piazza T, Cha E, Bongarzone I, Canevari S, Bolognesi A, Polito L, Bargellesi A, Sassi F, Ferrini S, Fabbi M. J Cell Sci; 2005 Apr 01; 118(Pt 7):1515-25. PubMed ID: 15769845 [Abstract] [Full Text] [Related]
13. The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells. Rosso O, Piazza T, Bongarzone I, Rossello A, Mezzanzanica D, Canevari S, Orengo AM, Puppo A, Ferrini S, Fabbi M. Mol Cancer Res; 2007 Dec 01; 5(12):1246-53. PubMed ID: 18171982 [Abstract] [Full Text] [Related]
14. Glycosylation-dependent binding of galectin-8 to activated leukocyte cell adhesion molecule (ALCAM/CD166) promotes its surface segregation on breast cancer cells. Fernández MM, Ferragut F, Cárdenas Delgado VM, Bracalente C, Bravo AI, Cagnoni AJ, Nuñez M, Morosi LG, Quinta HR, Espelt MV, Troncoso MF, Wolfenstein-Todel C, Mariño KV, Malchiodi EL, Rabinovich GA, Elola MT. Biochim Biophys Acta; 2016 Oct 01; 1860(10):2255-68. PubMed ID: 27130882 [Abstract] [Full Text] [Related]
15. Activated leukocyte cell adhesion molecule expression and shedding in thyroid tumors. Miccichè F, Da Riva L, Fabbi M, Pilotti S, Mondellini P, Ferrini S, Canevari S, Pierotti MA, Bongarzone I. PLoS One; 2011 Feb 22; 6(2):e17141. PubMed ID: 21364949 [Abstract] [Full Text] [Related]
16. Mitogen-activated protein kinase pathway activation by the CD6 lymphocyte surface receptor. Ibáñez A, Sarrias MR, Farnós M, Gimferrer I, Serra-Pagès C, Vives J, Lozano F. J Immunol; 2006 Jul 15; 177(2):1152-9. PubMed ID: 16818773 [Abstract] [Full Text] [Related]
17. Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis. Bech-Serra JJ, Santiago-Josefat B, Esselens C, Saftig P, Baselga J, Arribas J, Canals F. Mol Cell Biol; 2006 Jul 15; 26(13):5086-95. PubMed ID: 16782893 [Abstract] [Full Text] [Related]
18. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. Bowen MA, Patel DD, Li X, Modrell B, Malacko AR, Wang WC, Marquardt H, Neubauer M, Pesando JM, Francke U. J Exp Med; 1995 Jun 01; 181(6):2213-20. PubMed ID: 7760007 [Abstract] [Full Text] [Related]
19. The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker. Darvishi B, Boroumandieh S, Majidzadeh-A K, Salehi M, Jafari F, Farahmand L. Exp Mol Pathol; 2020 Aug 01; 115():104443. PubMed ID: 32380056 [Abstract] [Full Text] [Related]